My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
October 2008
Vol. 18 No. 10
Patient Care and Science
Drug Approvals, Recalls, Adverse Events Update
Rebecca Dotson

IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Recent alerts have included:

FDA Alert

CDC Alert

IDSA members can sign up for this service online. (You must be logged in to have access to this link.)
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Top Stories
SHEA, IDSA, and Partners Publish Strategies to Prevent Health Care-associated Infections
ID Specialists Have New Negotiating Tool
IDSA Journal Club, September 2008
Patient Care and Science
CDC Expands Testing Recommendations for Hepatitis B
EIN: Rates of a Rare Disease Rising?
Drug Approvals, Recalls, Adverse Events Update
In the IDSA Journals
Policy and Advocacy
HIV Travel and Immigration Ban Lifted—Sort Of
IDSA Advocacy Update: New Legislation Gives Incentives for Development of “Old” Antibiotics
Your Colleagues
Announcing the New IDSA/HIVMA Board Members
Congratulations to the 2008 Society Award Winners!
IDSA Congratulates the 2008 Joint Research Award Winners
Congratulations to This Year's HIVMA Leadership Award Winners!
Members on the Move
Welcome, New IDSA Members!
Education and Resources
New NIH Grant Submission Policy Allows Only One Resubmission
Spanish Version of Aspergillus Guidelines Published

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.